… people receiving candidate COVID-19 vaccines to understand … for prioritizing among the
COVID-19 vaccine candidates with … enhanced severity of COVID-19 disease, after vaccination. …

… status of the COVID-19 and the available treatments. Additionally, COVID-19 had created …
The review will help understand the current status of vaccines and other therapies while …

… and experience related to immunotherapy for 2019-nCoV. … , novel coronavirus, Immunotherapy,
interleukin, vaccine and the … So immunotherapy for this virus can also be a suitable option…

… that DC vaccine therapy may provide a potential treatment strategy to help combat COVID-19. …
In this review, we discuss DC vaccine therapy in the light of the body’s immunity, cancer, …

… immunotherapy affects a patient’s ability to mount protective immunity against COVID-19 after
vaccination… perform the VOICE study (‘vaccination against COVID in cancer’; ClinicalTrials.…

… recommendations for COVID-19 vaccine in … of COVID-19 infection, of COVID-19 vaccine,
of AIT and of biologicals and considered the data published for other anti-infectious vaccines …

… and safety of COVID-19 vaccines for patients with solid … Therefore, we aimed to assess the
impact of immunotherapy, … ) COVID-19 vaccine as part of the Vaccination Against COVID in …

… clinical data on the immunopathogenesis of the COVID-19 and review the innate and adaptive
… immunotherapies as well as reviewing recruiting/completed clinical trials of COVID-19. …

… Among them, we have developed a novel COVID-19 vaccine candidate based on the
Modified Vaccinia Virus Ankara (MVA) poxvirus vector expressing the entire SARS-CoV-2 S …

… feature prominently in COVID-19 pathophysiology. Host-… as immunomodulatory treatment
for COVID-19, while later on … guidance for immunotherapy of patients with COVID-19, on the …